Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentoxifylline dose optimization in preterm neonates with late-onset sepsis
NL-OMON24635Not yet recruiting
- Sponsor
- Erasmus MC
- Start
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of pentoxifylline in late-onset neonatal sepsis (LONS), sponsored by Erasmus MC. Primary endpoints: Optimal dose of pentoxifylline, Clinical response and 2 more. Planned start Sep 2019; status: not yet recruiting.
02
Drugs
pentoxifylline
03
Conditions
late-onset neonatal sepsis (LONS)
Beyond the preview
Go deeper on NL-OMON24635.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON24635.